In 2019, THC (Dronabinol) has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.

BACKGROUND: We have anecdotal evidence that THC may have contributed to disease control in a patient with acute undifferentiated leukemia.

You can read the full article here => https://www.theroc.us/researchlibrary/Dronabinol%20has%20preferential%20antileukemic%20activity%20in%20acute%20lymphoblastic%20and%20myeloid%20leukemia%20with%20lymphoid%20differentiation%20patterns.pdf